Login to Your Account



Nabriva lefamulin not a 'lung' shot thanks to specificity

By Randy Osborne
Staff Writer

Friday, April 21, 2017

Pharma giant Glaxosmithkline plc made "lemonade with lemons" using its pleuromutilin platform, Nabriva AG's chief medical officer (CMO), Elyse Seltzer, told BioWorld Today.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription